Cargando…

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.

Detalles Bibliográficos
Autores principales: Sponaas, Anne Marit, Waage, Anders, Vandsemb, Esten N., Misund, Kristine, Børset, Magne, Sundan, Anders, Slørdahl, Tobias Schmidt, Standal, Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928324/
https://www.ncbi.nlm.nih.gov/pubmed/33679794
http://dx.doi.org/10.3389/fimmu.2021.636375
_version_ 1783659831006068736
author Sponaas, Anne Marit
Waage, Anders
Vandsemb, Esten N.
Misund, Kristine
Børset, Magne
Sundan, Anders
Slørdahl, Tobias Schmidt
Standal, Therese
author_facet Sponaas, Anne Marit
Waage, Anders
Vandsemb, Esten N.
Misund, Kristine
Børset, Magne
Sundan, Anders
Slørdahl, Tobias Schmidt
Standal, Therese
author_sort Sponaas, Anne Marit
collection PubMed
description In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.
format Online
Article
Text
id pubmed-7928324
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79283242021-03-04 Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? Sponaas, Anne Marit Waage, Anders Vandsemb, Esten N. Misund, Kristine Børset, Magne Sundan, Anders Slørdahl, Tobias Schmidt Standal, Therese Front Immunol Immunology In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy. Frontiers Media S.A. 2021-02-15 /pmc/articles/PMC7928324/ /pubmed/33679794 http://dx.doi.org/10.3389/fimmu.2021.636375 Text en Copyright © 2021 Sponaas, Waage, Vandsemb, Misund, Børset, Sundan, Slørdahl and Standal. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sponaas, Anne Marit
Waage, Anders
Vandsemb, Esten N.
Misund, Kristine
Børset, Magne
Sundan, Anders
Slørdahl, Tobias Schmidt
Standal, Therese
Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title_full Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title_fullStr Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title_full_unstemmed Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title_short Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
title_sort bystander memory t cells and imid/checkpoint therapy in multiple myeloma: a dangerous tango?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928324/
https://www.ncbi.nlm.nih.gov/pubmed/33679794
http://dx.doi.org/10.3389/fimmu.2021.636375
work_keys_str_mv AT sponaasannemarit bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT waageanders bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT vandsembestenn bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT misundkristine bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT børsetmagne bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT sundananders bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT slørdahltobiasschmidt bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango
AT standaltherese bystandermemorytcellsandimidcheckpointtherapyinmultiplemyelomaadangeroustango